Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Retatrutide is an investigational drug not approved by the FDA
While Semaglutide (Ozempic, Wegovy) targets one receptor and Tirzepatide (Mounjaro, Zepbound) targets two, Retatrutide activates three distinct metabolic receptors simultaneously
Collagen Synthesis Enhancement GHK-Cu increases collagen production through multiple converging pathways
While the heart-specific targets of MOTS-c are still being investigated, these findings open the door to the peptides potential use in supporting cardiovascular health
Furthermore, at 12 weeks post-operation, no significant histological differences were found between any of the groups
US$ 26.98
US$ 29.29
US$ 23.21
US$ 27.23
